Insider Buy/Sell Details for the Healthcare Sector — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1586)
Wave Life Sciences Ltd. (WVE)
Francis Chris — SVP, Corporate Development, Head of Emerging Areas
Shares
1,883
Price
$13.45
Total Value
$25.33K
Shares Held After
61,867
% of Holdings
3.0%
Wave Life Sciences Ltd. (WVE)
Moran Kyle — Chief Financial Officer
Shares
3,588
Price
$13.45
Total Value
$48.26K
Shares Held After
134,385
% of Holdings
2.6%
Wave Life Sciences Ltd. (WVE)
BOLNO PAUL — Director
Shares
10,480
Price
$13.45
Total Value
$140.96K
Shares Held After
275,520
% of Holdings
3.7%
PULSE BIOSCIENCES, INC. (PLSE)
Danahy Kevin Patrick — Chief Commercial Officer
Shares
20,000
Price
$21.45
Total Value
$429.00K
Shares Held After
43,298
% of Holdings
31.6%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
2,171
Price
$30.21
Total Value
$65.59K
Shares Held After
50,437
% of Holdings
4.1%
Krystal Biotech, Inc. (KRYS)
ROMANO KATHRYN — Chief Accounting Officer
Shares
96
Price
$277.88
Total Value
$26.68K
Shares Held After
19,318
% of Holdings
0.5%
Krystal Biotech, Inc. (KRYS)
ROMANO KATHRYN — Chief Accounting Officer
Shares
400
Price
$275.68
Total Value
$110.27K
Shares Held After
19,414
% of Holdings
2.0%
Krystal Biotech, Inc. (KRYS)
ROMANO KATHRYN — Chief Accounting Officer
Shares
552
Price
$274.64
Total Value
$151.60K
Shares Held After
19,814
% of Holdings
2.7%
Krystal Biotech, Inc. (KRYS)
ROMANO KATHRYN — Chief Accounting Officer
Shares
928
Price
$273.71
Total Value
$254.00K
Shares Held After
20,366
% of Holdings
4.4%
Krystal Biotech, Inc. (KRYS)
ROMANO KATHRYN — Chief Accounting Officer
Shares
2,824
Price
$272.51
Total Value
$769.56K
Shares Held After
21,294
% of Holdings
11.7%
Krystal Biotech, Inc. (KRYS)
ROMANO KATHRYN — Chief Accounting Officer
Shares
5,700
Price
$271.66
Total Value
$1.55M
Shares Held After
24,118
% of Holdings
19.1%
Krystal Biotech, Inc. (KRYS)
ROMANO KATHRYN — Chief Accounting Officer
Shares
2,000
Price
$270.56
Total Value
$541.12K
Shares Held After
29,818
% of Holdings
6.3%
Roivant Sciences Ltd. (ROIV)
Sukhatme Mayukh — Director
Shares
339,441
Price
$26.47
Total Value
$8.99M
Shares Held After
19,148,664
% of Holdings
1.7%
Schrödinger, Inc. (SDGR)
Abel Robert Lorne — EVP, Chief Scientific Officer, Platform
Shares
1,230
Price
$13.51
Total Value
$16.62K
Shares Held After
19,385
% of Holdings
6.0%
SpyGlass Pharma, Inc. Common Stock (SGP)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
248,034
Price
$16.00
Total Value
$3.97M
Shares Held After
2,054,678
% of Holdings
12.1%
SpyGlass Pharma, Inc. Common Stock (SGP)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
3,441,966
Price
$16.00
Total Value
$55.07M
Shares Held After
5,966,439
% of Holdings
57.7%
THERMO FISHER SCIENTIFIC INC. (TMO)
Pettiti Gianluca — Executive Vice President
Shares
400
Price
$541.20
Total Value
$216.48K
Shares Held After
20,752
% of Holdings
1.9%
SpyGlass Pharma, Inc. Common Stock (SGP)
Chang Carmen — 10% Owner
Shares
937,500
Price
$16.00
Total Value
$15.00M
Shares Held After
6,035,038
% of Holdings
15.5%
SpyGlass Pharma, Inc. Common Stock (SGP)
Mathers Edward T — 10% Owner
Shares
937,500
Price
$16.00
Total Value
$15.00M
Shares Held After
6,035,038
% of Holdings
15.5%
SpyGlass Pharma, Inc. Common Stock (SGP)
Walker Paul Edward — 10% Owner
Shares
937,500
Price
$16.00
Total Value
$15.00M
Shares Held After
6,035,038
% of Holdings
15.5%
SpyGlass Pharma, Inc. Common Stock (SGP)
SANDELL SCOTT D — 10% Owner
Shares
937,500
Price
$16.00
Total Value
$15.00M
Shares Held After
6,035,038
% of Holdings
15.5%
SpyGlass Pharma, Inc. Common Stock (SGP)
Makhzoumi Mohamad — 10% Owner
Shares
937,500
Price
$16.00
Total Value
$15.00M
Shares Held After
6,035,038
% of Holdings
15.5%
SpyGlass Pharma, Inc. Common Stock (SGP)
Yang Rick — 10% Owner
Shares
937,500
Price
$16.00
Total Value
$15.00M
Shares Held After
6,035,038
% of Holdings
15.5%
SpyGlass Pharma, Inc. Common Stock (SGP)
New Enterprise Associates 17, L.P. — 10% Owner
Shares
937,500
Price
$16.00
Total Value
$15.00M
Shares Held After
6,035,038
% of Holdings
15.5%
SpyGlass Pharma, Inc. Common Stock (SGP)
Florence Anthony A. Jr. — 10% Owner
Shares
937,500
Price
$16.00
Total Value
$15.00M
Shares Held After
6,035,038
% of Holdings
15.5%
SpyGlass Pharma, Inc. Common Stock (SGP)
BASKETT FOREST — 10% Owner
Shares
937,500
Price
$16.00
Total Value
$15.00M
Shares Held After
6,035,038
% of Holdings
15.5%
SpyGlass Pharma, Inc. Common Stock (SGP)
Behbahani Ali — Director
Shares
937,500
Price
$16.00
Total Value
$15.00M
Shares Held After
6,035,038
% of Holdings
15.5%
Kiniksa Pharmaceuticals International, plc (KNSA)
Ragosa Mark — CHIEF FINANCIAL OFFICER
Shares
8,731
Price
$43.72
Total Value
$381.72K
Shares Held After
12,086
% of Holdings
41.9%
Kiniksa Pharmaceuticals International, plc (KNSA)
Ragosa Mark — CHIEF FINANCIAL OFFICER
Shares
9,114
Price
$42.85
Total Value
$390.53K
Shares Held After
20,817
% of Holdings
30.5%
INSMED Inc (INSM)
Lewis William — Director
Shares
1,287
Price
$148.83
Total Value
$191.54K
Shares Held After
301,185
% of Holdings
0.4%
INSMED Inc (INSM)
Lewis William — Director
Shares
7,221
Price
$148.02
Total Value
$1.07M
Shares Held After
302,472
% of Holdings
2.3%
INSMED Inc (INSM)
Lewis William — Director
Shares
4,888
Price
$147.17
Total Value
$719.37K
Shares Held After
309,693
% of Holdings
1.6%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
1
Price
$787.82
Total Value
$787.82
Shares Held After
17,803
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
2
Price
$786.29
Total Value
$1.57K
Shares Held After
17,804
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
1
Price
$785.71
Total Value
$785.71
Shares Held After
17,806
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
1
Price
$784.59
Total Value
$784.59
Shares Held After
17,807
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
3
Price
$783.34
Total Value
$2.35K
Shares Held After
17,808
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
1
Price
$782.53
Total Value
$782.53
Shares Held After
17,811
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
5
Price
$781.48
Total Value
$3.91K
Shares Held After
17,812
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
1
Price
$780.09
Total Value
$780.09
Shares Held After
17,817
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
5
Price
$779.41
Total Value
$3.90K
Shares Held After
17,818
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
12
Price
$778.53
Total Value
$9.34K
Shares Held After
17,823
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
57
Price
$777.56
Total Value
$44.32K
Shares Held After
17,835
% of Holdings
0.3%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
10
Price
$776.59
Total Value
$7.77K
Shares Held After
17,892
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
1
Price
$775.63
Total Value
$775.63
Shares Held After
17,902
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
Pitofsky Jason — SVP Controller
Shares
53
Price
$785.72
Total Value
$41.64K
Shares Held After
4,272
% of Holdings
1.2%
REGENERON PHARMACEUTICALS, INC. (REGN)
Pitofsky Jason — SVP Controller
Shares
1
Price
$784.66
Total Value
$784.66
Shares Held After
4,325
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
Pitofsky Jason — SVP Controller
Shares
144
Price
$783.23
Total Value
$112.79K
Shares Held After
4,326
% of Holdings
3.2%
REGENERON PHARMACEUTICALS, INC. (REGN)
Pitofsky Jason — SVP Controller
Shares
37
Price
$782.67
Total Value
$28.96K
Shares Held After
4,470
% of Holdings
0.8%
REGENERON PHARMACEUTICALS, INC. (REGN)
Pitofsky Jason — SVP Controller
Shares
26
Price
$781.37
Total Value
$20.32K
Shares Held After
4,507
% of Holdings
0.6%
Showing 1101–1150 of 1586 transactions (page 23 of 32)